Accessing Treatment for Crohn’s and Colitis

This webinar provided valuable insights into accessing and managing the costs of inflammatory bowel disease (IBD) treatments, from medications to medical supplies. Viewers learned about treatment options for Crohn’s and colitis, including approved medications such as biologics and biosimilars available in different regions.

Experts discussed key topics such as out-of-pocket costs, navigating insurance for both children and adults, and accessing financial support in Ontario, Manitoba, and Saskatchewan. Whether you’re looking for guidance on managing IBD treatment expenses or understanding coverage options, this webinar offers practical advice from leading experts. Watch the full session on YouTube.

Expert speaker

Noelle Rohatinsky (RN, MN, PhD, CMSN(C))
University of Saskatchewan

Dr. Noelle Rohatinsky (RN, MN, PhD, CMSN(C)) is an Associate Professor and Registered Nurse at the University of Saskatchewan. In 2018, Noelle received the Crohn’s and Colitis Canada Ross McMaster National Unsung Hero Award and has been volunteering with Crohn's and Colitis Canada for several years.

She has led Newly Diagnosed Nights to individuals in her community and nationally via our webinars. Her research focuses on enhancing health service delivery and access to care for individuals and families affected by IBD. Noelle herself was diagnosed with Crohn's disease in 2000. 

Speaker with lived-experience

Shanta Zurock (BScPharm, B.Comm)

Shanta Zurock (BScPharm, B.Comm) is a senior professional in the pharmaceutical environment. Experience as a clinical pharmacist, insurance drug plan manager, and pharmaceutical market access professional. Shanta has extensive knowledge of the health care, insurance, and drug environment in Canada.

 

 

Back

  • Canada has among the highest incidence rates of Crohn's and colitis in the world.
  • 1 in 140 Canadians lives with Crohn’s or colitis.
  • Families new to Canada are developing these diseases for the first time.
  • Incidence of Crohn’s in Canadian kids under 10 has doubled since 1995.
  • People are most commonly diagnosed before age 30.

Other Areas of Interest